MentionFox
Home › funding signals › Invert
Accelerator · announced

Invert (YC W22) — Data analytics software for biomanufacturing

Invert appears in Y Combinator's company directory in the Winter 2022 batch, listed 2022-03-25. Data analytics software for biomanufacturing..

Just raised? Share it.

Invert: Accepted into Y Combinator Winter 2022

What do you want to do with Invert?

Invert

New accelerator entry · 2022-03-25 · the record

Winter 2022
batch
25
people
Growth
stage
United States of America
region
Open the record →

In their words

We build software to manage, analyze, and optimize bioprocessing data. Our initial customers are bio-industrial companies, who produce various products in bioreactors.

What the record says

BatchWinter 2022
Announced2022-03-25
StageGrowth
StatusActive
Team size25
IndustryHealthcare
Sub-industryHealthcare -> Industrial Bio
SectorsCellular Agriculture, Machine Learning, Synthetic Biology, Biotech
RegionsUnited States of America, America / Canada, Remote, Fully Remote
BasedSan Francisco, CA, USA; Remote
HiringYes
Sitehttp://www.invertbio.com/
Previously known asInvert Bio

The full profile

Checking your access…

Is this you?

If you're behind Invert: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

Tools for this story

Each opens in a new tab, filled in for Invert. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-invert
Last updated 2026-09-26
Primary record: Y Combinator directory entry
Invert (YC W22) — Data analytics software for biomanufacturing. MentionFox, 2026-09-26. https://mentionfox.com/funding/yc-invert